Marshall Wace’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Marshall Wace’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-16,675	Closed	-$57K	–	1940
2018 Q3	$57K	Buy	+16,675	New	+$60.1K	﹤0.01%	1105
2018 Q2	–	Sell	-59,700	Closed	-$244K	–	914
2018 Q1	$244K	Buy	+59,700	New	+$278K	0.01%	495

Marshall Wace's KERX Position: Q4 2018 in Review

Marshall Wace sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 16,675 shares — an estimated $57K sold.

Marshall Wace first reported a position in KERX in Q1 2018 and held it in 2 quarters. The position peaked at $244K in Q1 2018. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

Marshall Wace reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
Marshall Wace sold 16,675 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $57K.
Marshall Wace first reported a position in Keryx Biopharmaceuticals Inc in Q1 2018 and held it in 2 quarters.
Marshall Wace's Keryx Biopharmaceuticals Inc position peaked at $244K in Q1 2018.
1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Marshall Wace's 13F filing for Q4 2018, filed 14 Feb 2019.